nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—gestational diabetes	0.927	1	CbGaD
Pseudoephedrine—NFATC1—adipose tissue—gestational diabetes	0.00441	0.135	CbGeAlD
Pseudoephedrine—IL2—uterus—gestational diabetes	0.00413	0.126	CbGeAlD
Pseudoephedrine—TNF—vagina—gestational diabetes	0.0035	0.107	CbGeAlD
Pseudoephedrine—NFATC1—head—gestational diabetes	0.00339	0.103	CbGeAlD
Pseudoephedrine—IL2—head—gestational diabetes	0.0031	0.0945	CbGeAlD
Pseudoephedrine—Etomidate—CYP19A1—gestational diabetes	0.00229	1	CrCbGaD
Pseudoephedrine—MAOA—Neurotransmitter Release Cycle—GLS2—gestational diabetes	0.00176	0.0468	CbGpPWpGaD
Pseudoephedrine—TNF—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.0014	0.0371	CbGpPWpGaD
Pseudoephedrine—TNF—Type II diabetes mellitus—ADIPOQ—gestational diabetes	0.0014	0.0371	CbGpPWpGaD
Pseudoephedrine—MAOA—islet of Langerhans—gestational diabetes	0.00124	0.0379	CbGeAlD
Pseudoephedrine—MAOA—embryo—gestational diabetes	0.0012	0.0367	CbGeAlD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—GCK—gestational diabetes	0.00106	0.0281	CbGpPWpGaD
Pseudoephedrine—ADRB1—adipose tissue—gestational diabetes	0.00101	0.0308	CbGeAlD
Pseudoephedrine—ADRA2A—islet of Langerhans—gestational diabetes	0.000954	0.0291	CbGeAlD
Pseudoephedrine—IL2—IL27-mediated signaling events—TNF—gestational diabetes	0.000945	0.0251	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokines and Inflammatory Response—TNF—gestational diabetes	0.000917	0.0243	CbGpPWpGaD
Pseudoephedrine—TNF—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.000869	0.023	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—RETN—gestational diabetes	0.000861	0.0228	CbGpPWpGaD
Pseudoephedrine—SLC6A3—head—gestational diabetes	0.000819	0.025	CbGeAlD
Pseudoephedrine—MAOA—uterus—gestational diabetes	0.000811	0.0247	CbGeAlD
Pseudoephedrine—ADRA1A—adipose tissue—gestational diabetes	0.0008	0.0244	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—gestational diabetes	0.000793	0.0242	CbGeAlD
Pseudoephedrine—ADRB1—head—gestational diabetes	0.000777	0.0237	CbGeAlD
Pseudoephedrine—SLC6A4—head—gestational diabetes	0.000751	0.0229	CbGeAlD
Pseudoephedrine—IL2—IL23-mediated signaling events—TNF—gestational diabetes	0.000713	0.0189	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—LEPR—gestational diabetes	0.000676	0.0179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.000662	0.0176	CbGpPWpGaD
Pseudoephedrine—SLC6A2—head—gestational diabetes	0.000661	0.0201	CbGeAlD
Pseudoephedrine—MAOA—vagina—gestational diabetes	0.000659	0.0201	CbGeAlD
Pseudoephedrine—MAOA—Biological oxidations—GGCT—gestational diabetes	0.000653	0.0173	CbGpPWpGaD
Pseudoephedrine—ADRA2A—uterus—gestational diabetes	0.000622	0.019	CbGeAlD
Pseudoephedrine—ADRA1A—head—gestational diabetes	0.000614	0.0187	CbGeAlD
Pseudoephedrine—IL2—Spinal Cord Injury—LEP—gestational diabetes	0.000609	0.0162	CbGpPWpGaD
Pseudoephedrine—MAOA—head—gestational diabetes	0.000609	0.0186	CbGeAlD
Pseudoephedrine—ADRA2A—adipose tissue—gestational diabetes	0.000608	0.0185	CbGeAlD
Pseudoephedrine—IL2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000599	0.0159	CbGpPWpGaD
Pseudoephedrine—IL2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.00056	0.0149	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.00053	0.0141	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.000513	0.0136	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000506	0.0134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—vagina—gestational diabetes	0.000506	0.0154	CbGeAlD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000471	0.0125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—head—gestational diabetes	0.000467	0.0142	CbGeAlD
Pseudoephedrine—IL2—Folate Metabolism—TNF—gestational diabetes	0.000448	0.0119	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000448	0.0119	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—MBL2—gestational diabetes	0.00044	0.0117	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.000432	0.0115	CbGpPWpGaD
Pseudoephedrine—MAOA—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000428	0.0114	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—NAMPT—gestational diabetes	0.000413	0.0109	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00041	0.0109	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000395	0.0105	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—TNF—gestational diabetes	0.000388	0.0103	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—GLS2—gestational diabetes	0.000388	0.0103	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000386	0.0102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—ADIPOQ—gestational diabetes	0.000382	0.0101	CbGpPWpGaD
Pseudoephedrine—CYP2D6—head—gestational diabetes	0.000362	0.011	CbGeAlD
Pseudoephedrine—SLC6A3—Neuronal System—GLS2—gestational diabetes	0.000361	0.00956	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000354	0.0094	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Monoamine Transport—TNF—gestational diabetes	0.000345	0.00914	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.000342	0.00907	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—ADIPOQ—gestational diabetes	0.000338	0.00895	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—NAMPT—gestational diabetes	0.000337	0.00894	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000336	0.00892	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—GCK—gestational diabetes	0.000334	0.00886	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.000319	0.00846	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000317	0.00841	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Monoamine Transport—TNF—gestational diabetes	0.000296	0.00786	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000292	0.00774	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000284	0.00754	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TNF—gestational diabetes	0.000282	0.00747	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000276	0.00731	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00027	0.00717	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Monoamine Transport—TNF—gestational diabetes	0.000263	0.00696	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MBL2—gestational diabetes	0.000256	0.0068	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000252	0.00668	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000251	0.00666	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000245	0.00651	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000239	0.00634	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RBP4—gestational diabetes	0.000239	0.00633	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—LEP—gestational diabetes	0.000238	0.0063	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000234	0.00622	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00023	0.0061	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00023	0.0061	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—CYP19A1—gestational diabetes	0.000227	0.00603	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000227	0.00602	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—LEP—gestational diabetes	0.000227	0.00601	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000226	0.00599	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000225	0.00597	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—LEPR—gestational diabetes	0.000217	0.00575	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MBL2—gestational diabetes	0.000217	0.00575	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000214	0.00568	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NAMPT—gestational diabetes	0.000214	0.00568	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—GCK—gestational diabetes	0.000213	0.00564	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—LEP—gestational diabetes	0.00021	0.00556	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000208	0.00551	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000197	0.00523	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000193	0.00511	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000186	0.00494	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000186	0.00494	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000186	0.00494	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—LEPR—gestational diabetes	0.000183	0.00486	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000173	0.00459	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MTNR1B—gestational diabetes	0.000171	0.00455	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—LEP—gestational diabetes	0.000171	0.00454	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RBP4—gestational diabetes	0.000167	0.00443	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000159	0.00423	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF2—gestational diabetes	0.000154	0.00407	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00015	0.00398	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000148	0.00393	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000147	0.00389	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MTNR1B—gestational diabetes	0.000145	0.00385	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RBP4—gestational diabetes	0.000141	0.00375	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—GCK—gestational diabetes	0.000141	0.00374	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000121	0.00322	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000119	0.00316	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000117	0.00311	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ADIPOQ—gestational diabetes	0.000116	0.00308	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000113	0.00299	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GGCT—gestational diabetes	0.000112	0.00296	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000106	0.0028	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	9.9e-05	0.00263	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GLS2—gestational diabetes	9.77e-05	0.00259	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	9.76e-05	0.00259	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—gestational diabetes	9.71e-05	0.00257	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF2—gestational diabetes	8.95e-05	0.00237	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—MTNR1B—gestational diabetes	8.48e-05	0.00225	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—MTNR1B—gestational diabetes	8.3e-05	0.0022	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF2—gestational diabetes	8.26e-05	0.00219	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—gestational diabetes	7.96e-05	0.00211	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—MTNR1B—gestational diabetes	7.7e-05	0.00204	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—LEP—gestational diabetes	7.62e-05	0.00202	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF2—gestational diabetes	7.57e-05	0.00201	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—MTNR1B—gestational diabetes	7.53e-05	0.002	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GGCT—gestational diabetes	7.47e-05	0.00198	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—LEP—gestational diabetes	7.21e-05	0.00191	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—MTNR1B—gestational diabetes	6.86e-05	0.00182	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GLS2—gestational diabetes	6.53e-05	0.00173	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—LEP—gestational diabetes	6.44e-05	0.00171	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—MTNR1B—gestational diabetes	6.38e-05	0.00169	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MTNR1B—gestational diabetes	6.23e-05	0.00165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MTNR1B—gestational diabetes	5.79e-05	0.00154	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF2—gestational diabetes	5.79e-05	0.00153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEPR—gestational diabetes	5.76e-05	0.00153	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEPR—gestational diabetes	5.63e-05	0.00149	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—FGF2—gestational diabetes	5.48e-05	0.00145	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NAMPT—gestational diabetes	5.35e-05	0.00142	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GCK—gestational diabetes	5.32e-05	0.00141	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF2—gestational diabetes	4.89e-05	0.0013	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GGCT—gestational diabetes	4.87e-05	0.00129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEPR—gestational diabetes	4.66e-05	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTNR1B—gestational diabetes	4.55e-05	0.00121	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTNR1B—gestational diabetes	4.45e-05	0.00118	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RBP4—gestational diabetes	4.43e-05	0.00118	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RBP4—gestational diabetes	4.34e-05	0.00115	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEPR—gestational diabetes	4.33e-05	0.00115	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GLS2—gestational diabetes	4.25e-05	0.00113	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP19A1—gestational diabetes	3.89e-05	0.00103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTNR1B—gestational diabetes	3.68e-05	0.000976	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RBP4—gestational diabetes	3.59e-05	0.000951	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NAMPT—gestational diabetes	3.58e-05	0.000948	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GCK—gestational diabetes	3.55e-05	0.000942	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTNR1B—gestational diabetes	3.42e-05	0.000907	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RBP4—gestational diabetes	3.33e-05	0.000884	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP19A1—gestational diabetes	2.6e-05	0.000689	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.33e-05	0.000618	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCK—gestational diabetes	2.32e-05	0.000614	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—gestational diabetes	2.02e-05	0.000536	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—gestational diabetes	1.98e-05	0.000524	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.69e-05	0.000449	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—gestational diabetes	1.64e-05	0.000434	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—gestational diabetes	1.54e-05	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—gestational diabetes	1.52e-05	0.000403	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—gestational diabetes	1.5e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—gestational diabetes	1.24e-05	0.00033	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—gestational diabetes	1.15e-05	0.000306	CbGpPWpGaD
